Search by Drug Name or NDC
NDC 70505-0220-60 Nitisinone 20 mg/1 Details
Nitisinone 20 mg/1
Nitisinone is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Analog Pharma. The primary component is NITISINONE.
Product Information
| NDC | 70505-0220 |
|---|---|
| Product ID | 70505-220_8f419112-c2e0-4234-b0d9-f98fbd5c6459 |
| Associated GPIs | |
| GCN Sequence Number | 074393 |
| GCN Sequence Number Description | nitisinone CAPSULE 20 MG ORAL |
| HIC3 | D7D |
| HIC3 Description | DRUGS TO TREAT HEREDITARY TYROSINEMIA |
| GCN | 39031 |
| HICL Sequence Number | 023253 |
| HICL Sequence Number Description | NITISINONE |
| Brand/Generic | Generic |
| Proprietary Name | Nitisinone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Nitisinone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | NITISINONE |
| Labeler Name | Analog Pharma |
| Pharmaceutical Class | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 I |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212390 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70505-0220-60 (70505022060)
| NDC Package Code | 70505-220-60 |
|---|---|
| Billing NDC | 70505022060 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (70505-220-60) / 60 CAPSULE in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2023-05-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |